CD19 and acute lymphoblastic leukemia: The down-regulation of CD19 mediated by anti-CD19 CAR T cells has not been described in ALL cells, but it has been demonstrated in normal B lymphocytes and chronic lymphocytic leukemia (CLL) cells.